The Sigma Healthcare Ltd (ASX: SIG) share price is in focus as the company reports strong Chemist Warehouse sales growth, with Australian stores up 16.7% and international stores up 24.7% to date this financial year.
Image source: Getty Images
What did Sigma Healthcare report?
- Australian Chemist Warehouse sales grew 16.7% year-to-date, with like-for-like growth of 14.4%
- International Chemist Warehouse sales rose 24.7%, like-for-like growth of 11.8%
- Ongoing uplift from GLP1 sales continues in Australia
- Entered a joint venture to launch Chemist Warehouse in the UK
- Committed to a new 23,000 square metre distribution centre in New Zealand
What else do investors need to know?
Sigma has signed a memorandum of understanding with GreenLight Healthcare to bring the Chemist Warehouse brand to the United Kingdom. The initial focus will be on rebranding up to five London area stores, with plans for more if successful.
The company is also investing approximately A$40 million in its New Zealand supply chain. A new distribution centre will support a growing NZ store network, aiming for more than 100 Chemist Warehouse locations long term.
What's next for Sigma Healthcare?
Sigma expects to launch its first Chemist Warehouse store in the UK by rebranding one of GreenLight's existing locations in London. Phase one will focus on up to five sites, with potential to expand further if these pilot stores perform well.
The new distribution centre in New Zealand is scheduled to begin operations in September 2026, with warehouse automation rolling out in the second half of 2027. This investment is designed to future-proof Sigma's supply chain as the New Zealand store network grows.
Sigma Healthcare share price snapshot
Over the past 12 months, Sigma Healthcare shares have declined 10%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 7% over the same period.
